pocketful logo
Gland Pharma Ltd logo

Gland Pharma Ltd

NSE: GLAND BSE: 543245

1904.40

(1.81%)

Tue, 19 May 2026, 09:49 pm

Gland Pharma Share Price Live Chart

1 Day

(1.81%)

No Result Found

Summary

  • Market Cap

    35574.21

  • Net Profit

    698.53

  • P/B

    2.87

  • Sector P/E

    35.36

  • P/E

    37.55

  • EV/EBITDA

    16.18

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.95

  • ROCE (Industry)

    16.47

  • RONW (Industry)

    14.44

  • ROE

    7.82

  • ROCE

    11.67

  • Debt/Equity

    0.04

  • EPS (TTM)

    63.37

  • Dividend Yield

    0.93

  • Book Value

    628.68

  • Interest Cover

    26.30

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters51.8351.8351.8351.8351.83
FII7.307.587.917.396.90
DII33.3532.9832.6432.8533.27
Public7.527.617.637.937.99
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

77.54

MACD

84.93

50 DMA

1757.61

200 DMA

1828.21

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2104.931924.931837.871744.931657.871564.931384.93
Fibonacci1924.931856.171813.691744.931676.171633.691564.93
Camarilla1800.301783.801767.301744.931734.301717.801701.30

Pivots Level: Classic

R3

+360

2104.93

R2

+180

1924.93

R1

+92.93

1837.87

1744.93
1744.93
Pivot Point
LTP: 2251.10

S1

-87.07

1657.87

S2

-180

1564.93

S3

-360

1384.93

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1971.36

  • 20-EMA

    1891.15

  • 30-EMA

    1851.00

  • 50-EMA

    1813.16

  • 100-EMA

    1790.50

  • 200-EMA

    1783.66

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026agm
15 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
28 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
14 Jul 2025dividendFinal Dividend - Rs. - 1814 Aug 2025
20 May 2025agm
20 May 2025dividend₹18.00 Dividend /Share14 Aug 2025
16 Jul 2024dividendFinal Dividend - Rs. - 2016 Aug 2024
22 May 2024dividend₹20.00 Dividend /Share16 Aug 2024
22 May 2024agm

Read More

Peer Comparison

Gland Pharma Ltd logo

Gland Pharma Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Gland Pharma Ltd About

Gland Pharma is primarily engaged in manufacturing injectable formulations. The Company’s shares are listed on BSE Limited and National Stock Exchange of India Limited.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1978

Headquarters

CEO

SRINIVAS SADU

Employees

Contact

Website icon

Website

http://www.glandpharma.com

Email icon

Email

investors@glandpharma.com

Phone icon

Phone

91-40-30510999

Location icon

Location

Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043

Read More

Gland Pharma Ltd Company History

YearHistory
2019
  • The company filed Dexrazoxane for Injection, its first filing with the National Medical Products Administration, China, and received clinical waiver
2020
  • Gland Pharma along with its partners MAIA Pharmaceuticals, Inc. and Athenex Pharmaceutical Division announce the launch of a Ready-to-Use Bivalirudin Injection in the United States of America
2021
  • Gland Pharma received approval for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
  • Gland Pharma receives Tentative Approval for Sugammadex Injection
  • Gland Pharma receives tentative approval for Cangrelor injection
2022
  • Gland Pharma enters into put option agreement to acquire 100% of Cenexi Group
  • Gland Pharma announces launch of Bortezomib for Injection in US market
2024
  • The Company received approval from the United States Food and Drug Administration (US FDA) for Plerixafor Injection

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy10162191588.6921 Mar 2025
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFbulkBuy8385561588.6921 Mar 2025
UBS PRINCIPAL CAPITAL ASIA LIMITEDbulkBuy8250001771.0519 Jun 2024
FOSUN PHARMA INDUSTRIAL PTE. LTD.bulkSell99000001771.8119 Jun 2024
LAKUMI TRUSTbulkSell61654861739.109 Apr 2024
NICOMAC MACHINERY PRIVATE LIMITEDbulkSell19554521735.3109 Apr 2024
BNP PARIBAS ARBITRAGEblockSell2577611936.9525 Jan 2024
SOCIETE GENERALEblockBuy2577611936.9525 Jan 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy11103001698.7209 Aug 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell11103001700.0209 Aug 2023

Read More

Gland Pharma Ltd News

Gland Pharma Schedules Investor Meetings in May 2026

Gland Pharma announces analyst and institutional investor meetings on May 21, 27, and 29, 2026, under SEBI Regulation 30 disclosure requirements.

18 May 2026

companies

Gland Pharma Posts Record FY26 Revenue & Profit

Gland Pharma reports record consolidated revenue of ₹64,307 Mn in FY26, up 14% YoY, with adj. PAT surging 50% YoY. Board recommends final dividend of ₹20 per share.

15 May 2026

companies

Gland Pharma Reappoints Naina Lal Kidwai as Independent Director

Gland Pharma's postal ballot special resolution to reappoint Ms. Naina Lal Kidwai as Independent Director passed with 94.18% votes in favour on May 14, 2026.

14 May 2026

companies

Gland Pharma: ₹27.55 Cr Block Trade on NSE

Gland Pharma recorded a block trade on NSE worth ₹27.55 crores, involving approximately 1,52,565 shares transacted at ₹1805.90 per share.

06 May 2026

equity-markets

Gland Pharma Promoters Declare No Share Encumbrance

Shanghai Fosun Pharmaceutical Group and Fosun Pharma Industrial declare zero share pledging for FY26, maintaining clean shareholding structure with no encumbrances on promoter holdings.

01 May 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800